STI-8591

· Zhejiang ACEA Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STI-8591, covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML) [Phase 1]